Cargando…
Omalizumab's efficacy and safety against chronic spontaneous urticaria
I have read the article titled, "Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China", by Wang et al with great interest. Nevertheless, there are a couple of questions raised in my mind. And clarification of some aspects of the study will he...
Autor principal: | Özdemir, Öner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458888/ https://www.ncbi.nlm.nih.gov/pubmed/37638362 http://dx.doi.org/10.1016/j.waojou.2023.100808 |
Ejemplares similares
-
OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011) -
Successful treatment of intractable chronic spontaneous urticaria with omalizumab in a patient with ovarian cancer
por: Hayama, Koremasa, et al.
Publicado: (2021) -
Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China()
por: Wang, Ao, et al.
Publicado: (2022) -
Sex differences in the efficacy of omalizumab in the treatment of
chronic spontaneous urticaria
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022) -
Efficacy and safety of omalizumab in Chinese patients with anti‐histamine refractory chronic spontaneous urticaria
por: Yuan, Weiru, et al.
Publicado: (2022)